Sometimes, Simple Is Best
Progress in ophthalmology doesn’t always come from increased complexity
Lauren Robertson | | Opinion
At the turn of a decade, it’s natural to wonder what progress will be made in science and medicine over the next 10 years – especially in a field like ophthalmology. Consider the countless strides made forward over the last few years alone – from the first FDA-approved autonomous AI device (IDx- DR) to the first US regulatory approval of a gene therapy to treat a retinal disease (Luxturna). Where will we be in 2030?
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.